featured
Antiplatelet Therapy and Survival in Moyamoya Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Heart Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study
J Am Heart Assoc 2021 Feb 22;[EPub Ahead of Print], WK Seo, JY Kim, EH Choi, YS Kim, JW Chung, JL Saver, OY Bang, GM KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.